Patients with amyotrophic lateral sclerosis, a debilitating and fatal neurological disease, have few treatment options. The scarcity helps explain why an experimental drug attracted attention earlier this year, as a small study found its use appeared to slow functional decline in people with rapidly advancing ALS.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,